Company Valuation: Boston Scientific Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 63,029 51,478 60,534 66,273 84,691 139,439 139,439 -
Change - -18.33% 17.59% 9.48% 27.79% 64.64% 0% -
Enterprise Value (EV) 1 72,820 58,887 67,674 74,280 92,928 147,924 144,932 141,535
Change - -19.13% 14.92% 9.76% 25.1% 59.18% -2.02% -2.34%
P/E ratio 13.6x -300x 61.6x 103x 54x 71.1x 50.8x 41.9x
PBR 4.54x 3.32x 3.64x 3.77x 4.39x 6.65x 5.83x 5.17x
PEG - 3x -0x -3x 0x 2.9x 1.3x 2x
Capitalization / Revenue 5.87x 5.19x 5.09x 5.23x 5.95x 8.4x 7.43x 6.74x
EV / Revenue 6.78x 5.94x 5.69x 5.86x 6.53x 8.91x 7.72x 6.84x
EV / EBITDA 23.4x 19.4x 16.5x 20.8x 22.6x 30x 26.1x 22.7x
EV / EBIT 26x 30.7x 22.5x 22.9x 24.9x 33x 28.2x 24.5x
EV / FCF 53x 52x 51.4x 79.2x 51.9x 55.1x 50.2x 36.9x
FCF Yield 1.89% 1.92% 1.94% 1.26% 1.93% 1.82% 1.99% 2.71%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 3.33 -0.12 0.69 0.45 1.07 1.33 1.862 2.261
Distribution rate - - - - - - - -
Net sales 1 10,735 9,913 11,888 12,682 14,240 16,599 18,765 20,694
EBITDA 1 3,111 3,040 4,103 3,574 4,106 4,929 5,550 6,240
EBIT 1 2,800 1,917 3,010 3,241 3,738 4,482 5,144 5,784
Net income 1 4,700 -173 985 642 1,570 1,968 2,773 3,373
Net Debt 1 9,791 7,409 7,140 8,007 8,237 8,485 5,493 2,096
Reference price 2 45.22 35.95 42.48 46.27 57.81 94.61 94.61 94.61
Nbr of stocks (in thousands) 1,393,824 1,431,921 1,424,992 1,432,311 1,464,983 1,473,827 1,473,827 -
Announcement Date 05/02/20 03/02/21 02/02/22 01/02/23 31/01/24 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio (Y) EV / Sales EV / EBITDA Yield (Y) Capi. ($)
71.15x8.91x30.01x-.--%139B
34.11x5.57x22.11x+0.27%212B
90.74x23.06x56.34x-.--%192B
42.93x7.89x25.17x+0.47%173B
24x2.91x13.68x+2.17%57.93B
30.81x6.47x21.29x-.--%41.93B
29.51x6.15x20.88x+0.70%40.54B
20.72x2.26x12.12x+0.13%39B
21.43x6.69x17.3x+2.87%38.18B
25.57x6.55x18.2x+0.99%33.82B
Average 39.10x 7.65x 23.71x +0.76% 96.88B
Weighted average by Cap. 49.98x 9.79x 29.27x +0.46%
See all sector valuations

Year-on-year evolution of the PER

evolution-chart BOSTON-SCIENTIFIC-CORPORA

Historical PBR trend

evolution-chart BOSTON-SCIENTIFIC-CORPORA

Evolution Enterprise Value / Sales

evolution-chart BOSTON-SCIENTIFIC-CORPORA

Change in Enterprise Value/EBITDA

evolution-chart BOSTON-SCIENTIFIC-CORPORA

Year-on-year evolution of the Yield

evolution-chart BOSTON-SCIENTIFIC-CORPORA
  1. Stock Market
  2. Equities
  3. BSX Stock
  4. Valuation Boston Scientific Corporation